Hutch News
Results per Page:
New Scientific Publications
Each week, Fred Hutch librarians search PubMed and Web of Science to discover new papers published by Fred Hutch authors
Week of June 28, 2020
A3C tandem domain proteins have increased anti-HIV-1 activity and are resistant to antagonism by HIV-1 Vif
From the Emerman laboratory, Human Biology Division
Injectable HIV drug prevents infections
Early data shows fewer infections than with daily pill; trial halted
TRIMs attack: TRIM34 and TRIM5alpha work together to block HIV-1 infection
From the Emerman laboratory, Human Biology and Basic Sciences Divisions
Cracking the code of HIV-1 entry into macaque cells
From the Bloom lab (Basic Sciences Division) and Overbaugh lab (Human Biology and Public Health Sciences Divisions).
When COVID-19 crosses paths with HIV
Survivors of one pandemic now brace for a new one
Dr. Julie Overbaugh elected to American Academy of Arts & Sciences
Her HIV research revealed factors that influence HIV transmission
Immune surveillance triggers HIV reactivation
From the Hladik lab, Vaccine and Infectious Disease Division
Defining the role of maternal neutralizing antibodies in mother-to-child HIV transmission
From the Overbaugh laboratory, Human Biology Division
Dr. Michael Emerman to give Bernard Fields lecture at CROI
Talk will cover how lessons from HIV’s evolutionary past could lead to new therapies, cure
Tip Sheet: Tracking coronavirus, improving immunotherapies, cancer death rates decline, AAAS meeting and more
SEATTLE – Feb. 3, 2020 – Below are summaries of recent Fred Hutch research findings with links for additional background and media contacts.
Dr. Hans-Peter Kiem speaks about HIV and making gene therapy more accessible at TEDxSeattle
His talk is now available online
Multi-step HIV-1 vaccines
From the Vaccine and Infectious Disease Division and the Chan Zuckerberg Biohub.
Science on the horizon
Fred Hutch experts make predictions for science trends, advances in 2020
CCR5 plays multiple roles in mucosal immunity
From the Prlic lab, Vaccine and Infectious Disease Division
World AIDS Day: Stepping up the search for a cure
New funding from Gates Foundation and NIH give vote of confidence for an audacious goal
Inflammatory mucosal T cells: harmful or helpful?
From the Lund lab, Vaccine and Infectious Disease Division
HIV vaccine trial uncovers plausible mechanisms of protection
From the HVTN, Vaccine and Infectious Disease Division
Tip Sheet: A clever way to make an AIDS vaccine; how a common cancer mutation actually drives cancer; and a new process that regulates red blood cell development
SEATTLE – Nov. 6, 2019 – Below are summaries of recent Fred Hutch research findings with links for additional background and media contacts.
New trial aims to curb HPV-related cancers in HIV+ women and children
International ‘dream team’ to use new technologies and prevention approaches to help those at highest risk
An old HIV vaccine surprises researchers once again
Designed for a Thailand strain of the AIDS virus, it stirred stronger immunity in South Africa